• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immediate local and systemic hypersensitivity due to etanercept and adalimumab.

作者信息

Hansel Katharina, Bianchi Leonardo, Tramontana Marta, Balato Anna, Scala Emanuele, Brozzi Jacopo, Stingeni Luca

机构信息

Section of Clinical, Allergological and Venereological Dermatology, Department of Medicine, University of Perugia, Perugia, Italy.

Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

出版信息

J Allergy Clin Immunol Pract. 2019 Feb;7(2):726-727. doi: 10.1016/j.jaip.2018.06.020. Epub 2018 Jul 10.

DOI:10.1016/j.jaip.2018.06.020
PMID:30006049
Abstract
摘要

相似文献

1
Immediate local and systemic hypersensitivity due to etanercept and adalimumab.因依那西普和阿达木单抗引起的即刻局部和全身超敏反应。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):726-727. doi: 10.1016/j.jaip.2018.06.020. Epub 2018 Jul 10.
2
Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis.类风湿关节炎和强直性脊柱炎患者队列中TNFα抑制剂的停药原因及不良反应
Ann Pharmacother. 2017 May;51(5):388-393. doi: 10.1177/1060028016682330. Epub 2016 Dec 5.
3
Direct Comparative Effectiveness Among 3 Anti-Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis.类风湿关节炎真实队列中3种抗肿瘤坏死因子生物制剂的直接比较疗效
J Clin Rheumatol. 2016 Mar;22(2):57-62. doi: 10.1097/RHU.0000000000000358.
4
Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.日本类风湿关节炎患者使用肿瘤坏死因子抑制剂治疗后发生耶氏肺孢子菌肺炎：三种药物的汇总分析
J Rheumatol. 2015 Sep;42(9):1726-8. doi: 10.3899/jrheum.141510.
5
Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients.12例患者使用快速皮下脱敏疗法治疗对依那西普和阿达木单抗的局部及全身超敏反应
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):629-32. doi: 10.1016/j.jaip.2015.01.009. Epub 2015 Feb 25.
6
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.一线抗TNF药物在成人和青少年发病的炎症性关节炎患者中的真实世界10年保留率：异同点
Clin Rheumatol. 2017 Aug;36(8):1747-1755. doi: 10.1007/s10067-017-3712-8. Epub 2017 Jun 8.
7
Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience.阿达木单抗、依那西普和英夫利昔单抗作为类风湿关节炎患者一线生物治疗药物在日常临床实践中的留存率——奥弗涅地区的经验
Int J Rheum Dis. 2018 Nov;21(11):1924-1932. doi: 10.1111/1756-185X.13156. Epub 2017 Sep 13.
8
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.类风湿关节炎患者中，24个月抗TNF治疗与甲氨蝶呤对体重的影响：一项前瞻性观察研究
Clin Rheumatol. 2016 Jun;35(6):1615-8. doi: 10.1007/s10067-016-3244-7. Epub 2016 Apr 6.
9
Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis.类风湿关节炎中肿瘤坏死因子拮抗剂停药比较的异质性——一项荟萃分析
PLoS One. 2016 Dec 8;11(12):e0168005. doi: 10.1371/journal.pone.0168005. eCollection 2016.
10
Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.类风湿关节炎一线肿瘤坏死因子抑制剂的12年保留率：来自本地登记处的真实数据
Arthritis Care Res (Hoboken). 2016 Apr;68(4):432-9. doi: 10.1002/acr.22788.

引用本文的文献

1
The Efficacy, Safety and Longevity of Biologic Treatments in Pediatric and Adult Psoriasis Patients: A Comparative Multi-Center, Real-Life Study.生物制剂治疗儿童和成人银屑病患者的疗效、安全性及长期效果：一项多中心、真实世界比较研究
Ann Dermatol. 2025 Apr;37(2):114-121. doi: 10.5021/ad.24.057.
2
World Workshop on Oral Medicine VII: Oral adverse effects to biologic agents in patients with inflammatory disorders. A scoping review.第七届世界口腔医学研讨会：炎症性疾病患者生物制剂的口腔不良反应。一项范围综述。
J Oral Pathol Med. 2023 Jan;52(1):1-8. doi: 10.1111/jop.13389. Epub 2022 Dec 13.
3
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.
生物治疗中的过敏反应和免疫相关不良事件。
Clin Rev Allergy Immunol. 2022 Jun;62(3):413-431. doi: 10.1007/s12016-021-08879-w. Epub 2021 Jul 28.
4
Dermatological Manifestations in Inflammatory Bowel Diseases.炎症性肠病的皮肤表现
J Clin Med. 2021 Jan 19;10(2):364. doi: 10.3390/jcm10020364.